纠正:整合网络药理学和转录组学以确定索拉索宁的抗骨髓瘤标和实验验证
Daihao Wei1,2, Minyu Li2, Dawei Chu2
1Department of Orthopedic, General Hospital of Ningxia Medical University, Yinchuan, Ningxia Hui Autonomous Region, Yinchuan, China.
Frontiers in oncology
|October 15, 2025
概括
这项研究纠正了先前发表的一篇文章的DOI. 校正确保了癌症研究 (fonc) 的准确引用和检索.
科学领域:
- 在瘤学瘤学.
- 生物医学研究生物医学研究
背景情况:
- 以前的出版物需要对其DOI.文章进行纠正.
- 准确的引用对于科学完整性和研究可重复性至关重要.
研究的目的:
- 为出版物提供正确的文章DOI.
- 确保研究的适当引用和可访问性.
主要方法:
- 发出了一个纠正通知.
- 对特定的物品提供正确的DOI.
主要成果:
- 文章DOI已经更新.
- 读者现在可以使用更正的DOI访问该文章.
结论:
- 校正确保了科学记录的完整性.
- 保持适当的归因和对研究的准入.
相关概念视频
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...